[Pharmacology of adrenergic substances].
D001949:Bretylium Compounds / Q000494:pharmacology; D004809:Ephedrine / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D004876:Ergot Alkaloids / Q000494:pharmacology; D004878:Ergotamine / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D007545:Isoproterenol / Q000494:pharmacology; D008750:Methyldopa / Q000494:pharmacology; D009526:Nialamide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010276:Parasympatholytics / Q000494:pharmacology; D010293:Pargyline / Q000494:pharmacology; D010624:Phenelzine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013268:Stimulation, Chemical; D013565:Sympatholytics / Q000494:pharmacology* / Q000627:therapeutic use; D013566:Sympathomimetics / Q000494:pharmacology* / Q000627:therapeutic use
D001949:Bretylium Compounds; D004876:Ergot Alkaloids; D007093:Imidazoles; D010276:Parasympatholytics; D013565:Sympatholytics; D013566:Sympathomimetics; D010656:Phenylephrine; D008750:Methyldopa; D012110:Reserpine; D010293:Pargyline; D007490:Iproniazid; D004809:Ephedrine; D007545:Isoproterenol; D010624:Phenelzine; D004878:Ergotamine; D009526:Nialamide; D009638:Norepinephrine; D004837:Epinephrine; D010646:Phentolamine; D006145:Guanethidine
Farmakolohiia adrenerhichnykh rechovyn.